Back to search

Article

Reliability of H3K27M Detection Using a Commercially Available Blood-based Comprehensive Genomic Profiling Test in Patients with Diffuse Midline Gliomas: Analysis of the Nationwide C- CAT Database in Japan

2025-11-07

Abstract excerpt

<title>Abstract</title> <p>Purpose This study aimed to assess the ability of FoundationOne Liquid CDx (F1 Liquid), a blood-based comprehensive genomic profiling test introduced in Japan in 2021, to detect the H3K27M mutation in patients with diffuse midline glioma using a nationwide database in Japan. Methods We identified patients with IDH-wildtype diffuse gliomas in midline locations registered in the Center fo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8b2589ad-f3c2-5745-a656-e26369b9a842
DOI
10.21203/rs.3.rs-7932452/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Reliability of H3K27M Detection Using a Commercially Available Blood-based Comprehensive Genomic Profiling Test in Patients with Diffuse Midline Gliomas: Analysis of the Nationwide C- CAT Database in JapanDOI 10.21203/rs.3.rs-7932452/v1
Select a neighboring publication to make it the new centre.